3.06
price up icon7.18%   0.205
after-market Handel nachbörslich: 3.04 -0.02 -0.65%
loading

Finanzdaten der Cognition Therapeutics Inc-Aktie (CGTX)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
1.47%
13.98
13.78 10.72 14.46 14.68
Operating Income/Loss
1.47%
-13.98
-13.78 -10.72 -14.46 -14.68
Income/Loss From Continuing Operations Before Tax
20.59%
-6.734
-8.48 -7.842 -9.937 -7.041
Income/Loss From Continuing Operations After Tax
20.59%
-6.734
-8.48 -7.842 -9.937 -7.041
Net Income/Loss
20.59%
-6.734
-8.48 -7.842 -9.937 -7.041
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
3.01%
63.69
61.83 1.6495 40.42 40.06
Diluted Average Shares
3.01%
63.69
61.83 1.6495 40.42 40.06
Basic Earnings Per Share
21.43%
-0.11
-0.14 -0.17 -0.25 -0.18
Diluted Earnings Per Share
21.43%
-0.11
-0.14 -0.17 -0.25 -0.18
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$24.78
price up icon 0.98%
$84.84
price up icon 1.00%
$24.80
price down icon 8.06%
$103.01
price down icon 1.70%
$134.53
price up icon 1.79%
biotechnology ONC
$300.14
price down icon 2.84%
Kapitalisierung:     |  Volumen (24h):